EMA otorga recomendación positiva para comercialización de la vacuna española frente a la COVID-19

Equipo editorial de Medscape | News | 31 March 2023

La vacuna de Hipra contra la COVID-19 es una vacuna de proteína recombinante adyuvada.

La Agencia Europea de Medicamentos (EMA) mediante el Comité de Medicamentos de Uso Humano (CHMP) recomendó ayer, 30 de marzo, la autorización de comercialización para Bimervax , la vacuna contra la COVID-19 desarrollada por Hipra .

La vacuna contra la COVID-19 de Hipra es una vacuna de proteína recombinante adyuvada, ...

EMA otorga recomendación positiva para comercialización de la vacuna española frente a la COVID-19

December Challenge

What are the maternal risk factors for cerebral palsy in children?

Are assisted reproductive technologies associated with an increased risk for cardiovascular disease in nulliparous women?

How do different dosages of gabapentin affect pain intensity in patients undergoing spine surgery?

Does the Mediterranean diet have protective effects on adverse pregnancy outcomes?

What is the most effective digitally assisted intervention to reduce glycated haemoglobin?

How effective is endoscopic screening in reducing the risk for gastric cancer mortality?

What is the association between apolipoproteins and metabolic syndrome?

Can tumour-infiltrating lymphocyte scores affect treatment decisions?

Do different exercise training modes have different effects on resting blood pressure?

How are neurocutaneous syndromes associated with central nervous system tumours in childhood?

Topic Challenges

Quiz challenge Emerging diseases: COVID-19

ESMO 2020 topic challenge

Women's health challenge

Antibiotics - Consequence of MDR carriage

Neurological disorders challenge

Rheumatology challenge

Lyme Disease

Mental health challenge

Topic challenge - Children conditions

Lyme Disease